HomeAI · summaries
Storia in 4 fonti
Hims & Hers posts $753M in Q2 revenue as it preps for push into peptide market
Digital health and wellness company Hims & Hers is ready to tap into a multi-billion dollar peptide market if U.S. regulators loosen restrictions on manufacturing. | Digital health and wellness company Hims & Hers is ready to tap into a multi-billion peptide market if U.S. regulators loosen restrictions on manufacturing.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
benzinga.com
Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earni
HIMS to release Q2 earnings on Aug. 10, expected to report a loss of 5 cents/share. FDA panel voted to add BPC-157 to compounding list. Stock rose 6.5% on Friday.
- ·
investors.com
Is Hims The Next Big Name In Peptides?
Hims stock inched lower Tuesday, recovering from a late-Monday dive.
